Holen Sie sich die Stockscreener-App
1.06
0.00%
0.00
Handel nachbörslich:
.88
-0.18
-16.98%
Schlusskurs vom Vortag:
$1.06
Offen:
$1.04
24-Stunden-Volumen:
1.01M
Relative Volume:
0.37
Marktkapitalisierung:
$561.80K
Einnahmen:
$75,000
Nettoeinkommen (Verlust:
$-42.41M
KGV:
-0.00589
EPS:
-179.8206
Netto-Cashflow:
$-18.47M
1W Leistung:
-38.01%
1M Leistung:
+809.87%
6M Leistung:
-84.75%
1J Leistung:
-97.98%
1-Tages-Spanne:
$0.98
$1.11
1-Wochen-Bereich:
$0.8608
$1.38
52-Wochen-Spanne:
$0.0801
$51.90
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
1.06 | 646.60K | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes - Yahoo Finance
Profusa signs term sheet to acquire diagnostics company By Investing.com - Investing.com South Africa
Why Is Profusa Stock Falling Monday? - Benzinga
Profusa Announces CEO Change and Plans to Acquire $111M Diagnostics Company in Major Growth Move 12 - Minichart
Profusa Announces Key Management Changes And Signing Of Non-Binding Term Sheet For The Acquisition Of A Commercial Stage Diagnostics Company - TradingView
Profusa: Ben Hwang Has Transitioned Into the Role of President of Profusa >PFSA - Moomoo
Profusa Plans Strategic Acquisition in Diagnostics Expansion - TipRanks
Profusa signs term sheet to acquire diagnostics company - Investing.com
Profusa (PFSA) pursues diagnostics acquisition and plans $7M convertible financing - Stock Titan
PFSA|Profusa Ord Shs|Price:1.710|Chg%:-0.050 - TradingKey
Profusa Names Jack Stover CEO; Ben Hwang Becomes President - Stock Titan
Profusa, Inc. Revenue Breakdown – NASDAQ:PFSA - TradingView
Profusa Ord Shs (PFSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Enterprise value to revenue forward of PROFUSA, INC. – OTC:NVACW - TradingView
Price to sales forward of PROFUSA, INC. – OTC:NVACW - TradingView
Price to earnings forward of PROFUSA, INC. – OTC:NVACW - TradingView
Strategy, Trump Media, Sequans, Blockchain Group, and Profusa scoop $2.9B BTC off the market - MSN
Profusa approves 1-for-25 reverse stock split; shares tumble - MSN
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year - Stocktwits
Profusa Stock Short Interest Rises to 44.46% - Quiver Quantitative
Profusa files resale prospectus for up to 7,170,891 shares - scanx.trade
Profusa (PFSA) registers 23,194 resale shares; 1-for-25 reverse split cut float - Stock Titan
Profusa (PFSA) registers 7.17M resale shares and effects 1:25 reverse split - Stock Titan
Profusa (NASDAQ: PFSA) registers 22,716-share resale following 1:25 reverse split - Stock Titan
Profusa Announces 1-for-25 Reverse Stock Split Effective July 7, 2026 to Maintain Nasdaq Listing - Minichart
Profusa Implements 1-for-25 Reverse Stock Split on Nasdaq - TipRanks
Profusa (NASDAQ: PFSA) enacts 1-for-25 reverse stock split, cuts share count - Stock Titan
Profusa announces reverse stock split - Medical Buyer
PFSA Should I Buy - Intellectia AI
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa announces 1-for-25 reverse stock split effective July 7 - Investing.com Australia
Profusa Announces 1-for-25 Reverse Stock Split Effective July 7, 2026 - Quiver Quantitative
Profusa to cut shares 25-to-1 before Nasdaq trading opens July 7 - Stock Titan
Profusa Announces 1-for-25 Reverse Stock Split - The Manila Times
Enterprise value to revenue forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Price to book forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Enterprise value to EBITDA forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Price to earnings forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Company Profile & Introduction - Moomoo
Profusa Inc. (PFSA) Slips 9.23% as Stock Tests Key Support at $0.11Buffered ETF - dars.gov.et
At the 2026 annual meeting, Profusa Inc’s shareholders formally approved a series of key strategic initiatives. - Bitget
Which stocks are most active on Wednesday? - ChartMill
Profusa Shareholders Approve Reverse Split and Governance Changes - The Globe and Mail
Profusa shareholders approve acquisition, debt conversion proposals By Investing.com - Investing.com South Africa
Profusa (NASDAQ:PFSA) Advances Biosensing and Diagnostics Expansion - Kalkine Media
Profusa shareholders approve acquisition, debt conversion proposals - Investing.com
Profusa wins shareholder backing for PanOmics deal and Nasdaq push - Stock Titan
Profusa Inc. (PFSA) Plunges 15.97%: Testing Critical Support LevelsBreakout Trade - dars.gov.et
Form 8K Profusa Inc For: 23 June By Investing.com - Investing.com South Africa
Profusa stockholders approve board proposals including director election and reverse split authorization - Investing.com UK
Finanzdaten der Profusa Inc-Aktie (PFSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):